| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_c7ad58d3c0b071069a8ee0cb8c8ba2e8 |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2770-32122
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2770-32134
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K39-00 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P31-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K14-005
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P37-04 |
| classificationIPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K39-00 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K39-125
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K39-135
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N15-42
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K14-09 |
| filingDate |
1997-09-08-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate |
2006-01-10-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_410ffcb8d3a8824ee651712b3505d585
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_8127cd531dcb169b883077a7fcd24628
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_05ed25e1fde3c6f0905cd4d4d0f1623c
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_76d8922c827e161f17bc18543bf79fc9
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_4d15705bff20b909c657debb9caa010b
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_c50bf292c31ea329fd49adf3d08b69a9
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_0dddb9206267175ca0c16f32400d8e05
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_2f526e5a04b35d6d9047bad69671e0ef |
| publicationDate |
2006-01-10-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
US-6984387-B1 |
| titleOfInvention |
Immunogenic peptides of foot-and-mouth disease viruses |
| abstract |
The present invention relates to FMDC vaccine based on peptides having a sequence of at least 8 amino acids, which corresponds to a partial sequence of the non-structural protein region of FMDV, which was selected by immunoreactivity with FMDV-specific antibodies or by immunoreactivity with FMDV-specific T lymphocytes, and to their production and their use. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11009671-B2 |
| priorityDate |
1996-09-18-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |